Business MODEL

CUTANEON develops patent-protected preclinical proofs-of-concept and early-stage clinical data sets and identifies novel actives that serve as a basis for bringing game-changing skin & hair products to market and promise to be expandable to product pipelines.

Our primary business model is to team-up with carefully selected industry partners on well-defined co-development projects. Typically, these are based on a patent-protected proof-of-principle, previously generated by CUTANEON that is geared towards the joint development of innovative skin & hair products.

Alternatively, an industry partner can also team-up with CUTANEON to conceive & design a co-development project from scratch at a novel skin & hair research frontier that the industry partner wishes to occupy and for which development of an innovative product pipeline is desired.

Typically, the R&D costs and project outcomes (e.g., new IP, proprietary data) of these co-development projects are being shared between the industry partner and CUTANEON, with clearly defined milestones and exit options. The industry partner has exclusivity for acquiring the entire jointly generated new IP under pre-agreed conditions and/or can out-license CUTANEON’s patent(s).
CUTANEON also offers investment opportunities into innovative, early-stage product development as well as in the company itself.